Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons

Abstract In Alzheimer's disease (AD), dysfunctional mitochondrial metabolism is associated with synaptic loss, the major pathological correlate of cognitive decline. Mechanistic insight for this relationship, however, is still lacking. Here, comparing isogenic wild‐type and AD mutant human indu...

Full description

Bibliographic Details
Main Authors: Alexander Y. Andreyev, Hongmei Yang, Paschalis‐Thomas Doulias, Nima Dolatabadi, Xu Zhang, Melissa Luevanos, Mayra Blanco, Christine Baal, Ivan Putra, Tomohiro Nakamura, Harry Ischiropoulos, Steven R. Tannenbaum, Stuart A. Lipton
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202306469
_version_ 1797242658043723776
author Alexander Y. Andreyev
Hongmei Yang
Paschalis‐Thomas Doulias
Nima Dolatabadi
Xu Zhang
Melissa Luevanos
Mayra Blanco
Christine Baal
Ivan Putra
Tomohiro Nakamura
Harry Ischiropoulos
Steven R. Tannenbaum
Stuart A. Lipton
author_facet Alexander Y. Andreyev
Hongmei Yang
Paschalis‐Thomas Doulias
Nima Dolatabadi
Xu Zhang
Melissa Luevanos
Mayra Blanco
Christine Baal
Ivan Putra
Tomohiro Nakamura
Harry Ischiropoulos
Steven R. Tannenbaum
Stuart A. Lipton
author_sort Alexander Y. Andreyev
collection DOAJ
description Abstract In Alzheimer's disease (AD), dysfunctional mitochondrial metabolism is associated with synaptic loss, the major pathological correlate of cognitive decline. Mechanistic insight for this relationship, however, is still lacking. Here, comparing isogenic wild‐type and AD mutant human induced pluripotent stem cell (hiPSC)‐derived cerebrocortical neurons (hiN), evidence is found for compromised mitochondrial energy in AD using the Seahorse platform to analyze glycolysis and oxidative phosphorylation (OXPHOS). Isotope‐labeled metabolic flux experiments revealed a major block in activity in the tricarboxylic acid (TCA) cycle at the α‐ketoglutarate dehydrogenase (αKGDH)/succinyl coenzyme‐A synthetase step, metabolizing α‐ketoglutarate to succinate. Associated with this block, aberrant protein S‐nitrosylation of αKGDH subunits inhibited their enzyme function. This aberrant S‐nitrosylation is documented not only in AD‐hiN but also in postmortem human AD brains versus controls, as assessed by two separate unbiased mass spectrometry platforms using both SNOTRAP identification of S‐nitrosothiols and chemoselective‐enrichment of S‐nitrosoproteins. Treatment with dimethyl succinate, a cell‐permeable derivative of a TCA substrate downstream to the block, resulted in partial rescue of mitochondrial bioenergetic function as well as reversal of synapse loss in AD‐hiN. These findings have therapeutic implications that rescue of mitochondrial energy metabolism can ameliorate synaptic loss in hiPSC‐based models of AD.
first_indexed 2024-04-24T18:42:43Z
format Article
id doaj.art-4b2d8ce6444d4cbcb0c378825ef1c175
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-04-24T18:42:43Z
publishDate 2024-03-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-4b2d8ce6444d4cbcb0c378825ef1c1752024-03-27T09:39:53ZengWileyAdvanced Science2198-38442024-03-011112n/an/a10.1002/advs.202306469Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human NeuronsAlexander Y. Andreyev0Hongmei Yang1Paschalis‐Thomas Doulias2Nima Dolatabadi3Xu Zhang4Melissa Luevanos5Mayra Blanco6Christine Baal7Ivan Putra8Tomohiro Nakamura9Harry Ischiropoulos10Steven R. Tannenbaum11Stuart A. Lipton12Department of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Biological Engineering Massachusetts Institute of Technology Cambridge MA 02139 USAChildren's Hospital of Philadelphia Research Institute and Departments of Pediatrics and Pharmacology Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania Philadelphia PA 19104 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USADepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USAChildren's Hospital of Philadelphia Research Institute and Departments of Pediatrics and Pharmacology Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania Philadelphia PA 19104 USANortheast Asia Institute of Chinese Medicine Changchun University of Chinese Medicine Changchun 130021 ChinaDepartment of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USAAbstract In Alzheimer's disease (AD), dysfunctional mitochondrial metabolism is associated with synaptic loss, the major pathological correlate of cognitive decline. Mechanistic insight for this relationship, however, is still lacking. Here, comparing isogenic wild‐type and AD mutant human induced pluripotent stem cell (hiPSC)‐derived cerebrocortical neurons (hiN), evidence is found for compromised mitochondrial energy in AD using the Seahorse platform to analyze glycolysis and oxidative phosphorylation (OXPHOS). Isotope‐labeled metabolic flux experiments revealed a major block in activity in the tricarboxylic acid (TCA) cycle at the α‐ketoglutarate dehydrogenase (αKGDH)/succinyl coenzyme‐A synthetase step, metabolizing α‐ketoglutarate to succinate. Associated with this block, aberrant protein S‐nitrosylation of αKGDH subunits inhibited their enzyme function. This aberrant S‐nitrosylation is documented not only in AD‐hiN but also in postmortem human AD brains versus controls, as assessed by two separate unbiased mass spectrometry platforms using both SNOTRAP identification of S‐nitrosothiols and chemoselective‐enrichment of S‐nitrosoproteins. Treatment with dimethyl succinate, a cell‐permeable derivative of a TCA substrate downstream to the block, resulted in partial rescue of mitochondrial bioenergetic function as well as reversal of synapse loss in AD‐hiN. These findings have therapeutic implications that rescue of mitochondrial energy metabolism can ameliorate synaptic loss in hiPSC‐based models of AD.https://doi.org/10.1002/advs.202306469Alzheimer's diseasesS‐nitrosylationtricarboxylic acid cycles
spellingShingle Alexander Y. Andreyev
Hongmei Yang
Paschalis‐Thomas Doulias
Nima Dolatabadi
Xu Zhang
Melissa Luevanos
Mayra Blanco
Christine Baal
Ivan Putra
Tomohiro Nakamura
Harry Ischiropoulos
Steven R. Tannenbaum
Stuart A. Lipton
Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons
Advanced Science
Alzheimer's diseases
S‐nitrosylation
tricarboxylic acid cycles
title Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons
title_full Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons
title_fullStr Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons
title_full_unstemmed Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons
title_short Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons
title_sort metabolic bypass rescues aberrant s nitrosylation induced tca cycle inhibition and synapse loss in alzheimer s disease human neurons
topic Alzheimer's diseases
S‐nitrosylation
tricarboxylic acid cycles
url https://doi.org/10.1002/advs.202306469
work_keys_str_mv AT alexanderyandreyev metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT hongmeiyang metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT paschalisthomasdoulias metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT nimadolatabadi metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT xuzhang metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT melissaluevanos metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT mayrablanco metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT christinebaal metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT ivanputra metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT tomohironakamura metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT harryischiropoulos metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT stevenrtannenbaum metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons
AT stuartalipton metabolicbypassrescuesaberrantsnitrosylationinducedtcacycleinhibitionandsynapselossinalzheimersdiseasehumanneurons